These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21270271)

  • 1. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
    Nathan DM; Lachin J; Cleary P; Orchard T; Brillon DJ; Backlund JY; O'Leary DH; Genuth S; ;
    N Engl J Med; 2003 Jun; 348(23):2294-303. PubMed ID: 12788993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
    Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
    Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF; Backlund JC; Budoff M; Raskin P; Bebu I; Lachin JM;
    J Am Heart Assoc; 2021 Dec; 10(24):e022922. PubMed ID: 34873921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM; Orchard TJ; Nathan DM;
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Timothy Garvey W; Lyons TJ;
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
    Lopes-Virella MF; Carter RE; Gilbert GE; Klein RL; Jaffa M; Jenkins AJ; Lyons TJ; Garvey WT; Virella G;
    Diabetes Care; 2008 Oct; 31(10):2006-12. PubMed ID: 18628568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.
    Markus RA; Mack WJ; Azen SP; Hodis HN
    Am J Clin Nutr; 1997 Apr; 65(4):1000-4. PubMed ID: 9094885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasonographic evaluation of selected parameters of the endothelial function in brachial arteries and IMT measurements in carotid arteries in children with diabetes type 1 using personal insulin pumps--preliminary report].
    Tołwińska J; Głowińska-Olszewska B; Urban M; Florys B; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):200-4. PubMed ID: 17020656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression factors of carotid intima-media thickness and plaque in patients with long-term, early-onset type 1 diabetes mellitus in Japan: simultaneous comparison with diabetic retinopathy.
    Ogawa Y; Uchigata Y; Iwamoto Y
    J Atheroscler Thromb; 2009; 16(6):821-8. PubMed ID: 19763015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
    Basu A; Jenkins AJ; Stoner JA; Thorpe SR; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2014 Sep; 236(1):188-195. PubMed ID: 25063949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study.
    Ito H; Komatsu Y; Mifune M; Antoku S; Ishida H; Takeuchi Y; Togane M
    Cardiovasc Diabetol; 2010 May; 9():18. PubMed ID: 20470427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.